Normal bronchial blood flow in COPD is unaffected by inhaled corticosteroids and correlates with exhaled nitric oxide

Chest

Volumn 131, Issue 4, 2007, Pages 1075-1081

  Paredi, Paolo ^a   Ward, Simon ^b   Cramer, Derek ^b   Barnes, Peter J ^a   Kharitonov, Sergei A ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Bronchial blood flow; COPD; Inflammation; Nitric oxide

Indexed keywords

BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; NITRIC OXIDE; SALBUTAMOL;

ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DRUG EFFECT; EXPIRED AIR; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LONG TERM CARE; LUNG BLOOD FLOW; MALE; PRIORITY JOURNAL; SHORT COURSE THERAPY; SMOKING; STATISTICAL ANALYSIS; VOLUNTEER;

EID: 34247191626     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-2154     Document Type: Article

References (39)

1. Jeffery PK. Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004; 1:176-183
2. Reid A, Heard BE. Preliminary studies of human pulmonary capillaries by India ink injection. Med Thorac 1962; 19:599-790
3. Cudkowicz L. The bronchial arteries in pulmonary emphysema. Thorax 1953; 8:46-58
4. Hashimoto M, Tanaka H, Abe S. Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD. Chest 2005; 127:965-972
5. Paredi P, Kharitonov SA, Barnes PJ. Correlation of exhaled breath temperature with bronchial blood flow in asthma. Respir Res 2005; 6:15
6. Hecht SS. Approaches to cancer prevention based on an understanding of N-nitrosamine carcinogenesis. Proc Soc Exp Biol Med 1997; 216:181-191
7. Tanaka H, Yamada G, Saikai T, et al. Increased airway vascularity in newly diagnosed asthma using a high-magnification bronchovideoscope. Am J Respir Crit Care Med 2003; 168:1495-1499
8. Wiesmann F, Petersen SE, Leeson PM, et al. Global impairment of brachial, carotid, and aortic vascular function in young smokers: direct quantification by high-resolution magnetic resonance imaging. J Am Coll Cardiol 2004; 44:2056-2064
9. Wanner A, Campos MA, Mendes E. Airway, blood flow reactivity in smokers. Pulm Pharmacol Ther 2007; 20:126-129
10. Rahman I, Morrison D, Donaldson K, et al. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 1996; 154:105.5-1060
11. Chediak AD, Elsasser S, Csete ME, et al. Effect of histamine on tracheal mucosal perfusion, water content and airway smooth muscle in sheep. Respir Physiol 1991; 84:231-243
12. Laitinen LA, Laitinen MA, Widdicombe JG. Dose-related effects of pharmacological mediators on tracheal vascular resistance in dogs. Br J Pharmacol 1987; 92:703-709
13. McDonald DM. Neurogenic inflammation in the respiratory tract: actions of sensory nerve mediators on blood vessels and epithelium of the airway mucosa. Am Rev Respir Dis 1987; 136:S65-S72
14. Bjork J, Smedegard G. Acute microvascular effects of PAF-acether, as studied by intravital microscopy. Eur J Pharmacol 1983; 96:87-94
15. Roland M, Bhowmik A, Sapsford RJ, et al. Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease. Thorax 2001; 56:30-35
16. Kanazawa H, Asai K, Hirata K, et al. Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Am J Med 2003; 114:354-358
17. Albro PW, Chae K, Philpot R, et al. In vitro metabolism of mono-2-ethylhexyl phthalate by microsomal enzymes: similarity to omega- and (omega-1) oxidation of fatty acids. Drug Metab Dispos 1984; 12:742-748
18. Papi A, Romagnoli M, Baraldo S, et al. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162:1773-1777
19. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276
20. Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations: the European Respiratory Society Task Force. Eur Respir J 1997; 10:1683-1693
21. Scuri M, McCaskill V, Chediak AD, et al. Measurement of airway mucosal blood flow with dimethylether: validation with microspheres. J Appl Physiol 1995; 79:1386-1390
22. Brieva JL, Danta I, Wanner A. Effect of an inhaled glucocorticosteroid on airway mucosal blood flow in mild asthma. Am J Respir Crit Care Med 2000; 161:293-296
23. Jibelian G, Mitchell RR, Overland ES. Influence of hematocrit and temperature on solubility of acetylene and dimethyl ether. J Appl Physiol 1981; 51:1357-1361
24. Paredi P, Caramori G, Cramer D, et al. Slower rise of exhaled breath temperature in COPD Slower rise of exhaled breath temperature in COPD. Eur Respir J 2003; 21:439-443
25. Kumar SD, Emery MJ, Atkins ND, et al. Airway mucosal blood flow in bronchial asthma. Am J Respir Crit Care Med 1998; 1998; 158:153-156
26. Mendes ES, Pereira A, Danta I, et al. Comparative bronchial vasoconstrictive efficacy of inhaled glucocorticosteroids. Eur Respir J 2003; 21:989-993
27. Kharitonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343:133-135
28. Paredi P, Kharitonov SA, Loukides S, et al. Exhaled nitric oxide is increased in active fibrosing alveolitis. Chest 1999; 115:1352-1356
29. Maziak W, Loukides S, Culpitt S, et al. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:998-1002
30. Kanazawa H, Shoji S, Yoshikawa T, et al. Increased production of endogenous nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease. Clin Exp Allergy 1998; 28:1244-1250
31. Rutgers SR, van der Mark TW, Coers W, et al. Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease. Thorax 1999; 54:576-580
32. Clini E, Bianchi L, Pagani M, et al. Endogenous nitric oxide in patients with stable COPD: correlates with severity of disease. Thorax 1998; 53:881-883
33. Paredi P, Kharitonov SA, Leak D, et al. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 369-373
34. Culpitt SV, Maziak W, Loukidis S, et al. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:1635-1639
35. Keatings VM, Jatakanon A, Worsdell YM, et al. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155:542-548
36. Fagan KA, Tyler RC, Sato K, et al. Relative contributions of endothelial, inducible, and neuronal NOS to tone in the murine pulmonary circulation. Am J Physiol 1999; 277:L472-L478
37. Chorley BN, Li Y, Fang S, et al. (R)-albuterol elicits antiinflammatory effects in human airway epithelial cells via iNOS. Am J Respir Cell Mol Biol 2006; 34:119-127
38. Kharitonov SA, Donnelly LE, Montuschi P, et al. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax 2002; 57:889-896
39. Paredi P, Ward S, Cramer D, et al. Exhaled ethane is increased in COPD and correlates with airway obstruction. Am J Respir Crit Care Med 2000; 162:369-373